$15.080
-0.911 (-6.04%)At close
CHRN News
CHRN Events
ChronoScale Shares Drop 14% to $12.80
ChronoScale is down -14.0%, or -$2.08 to $12.80.
ChronoScale Shares Drop 13.5% to $15.46
ChronoScale is down -13.5%, or -$2.42 to $15.46.
ChronoScale Shares Drop 13.0% to $15.55
ChronoScale is down -13.0%, or -$2.33 to $15.55.
ChronoScale Files $500M Mixed Securities Shelf
ChronoScale files $500M mixed securities shelf
ChronoScale Expands Customer Agreements, Projects $1B Revenue by Q3 2027
ChronoScale announced an expansion of an existing customer agreement and a separate agreement with a new customer, that increases the scale of its contracted AI infrastructure deployments and strengthens the company's contracted revenues. Together with ChronoScale's existing customer contracts and current deployment schedule, these two agreements provide for annualized run-rate revenue of $1B by calendar Q3 2027. Achievement and timing of this contracted revenue remain subject to a number of risks and uncertainties. ChronoScale also completed the sale of its Ekso Bionics business unit, which the company believes will allow it to focus its operations, management resources and capital allocation on its core accelerated compute and AI infrastructure business. The divestiture follows the formation of ChronoScale through the strategic combination of Applied Digital's cloud business and Ekso Bionics Holdings. ChronoScale now operates as an independent public company focused on scalable GPU-based infrastructure optimized for AI training, inference and high-performance computing.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.




